Abstract: An assembly process for a vehicle of substantial height, process in which at least one pit is implemented that is able to accommodate the vehicle, the latter being positioned on at least one removable floor platform able to raise the vehicle with respect to the bottom of the pit, the floor platform being positioned at the required height by means of positioning means.

Abstract: A method and apparatus for handling a wheel of large mass from a storage position to enable its mounting onto the hub of a vehicle, wherein the method includes placing a tire in a handling device having two ends which are of substantially equal length, the length being longer than the perimeter of the wheel, between two ends of the handling device, bringing together the ends of the handling device so as to imprison the wheel within the handling device, and hooking the ends of the handling device into a handling and lifting device.

Abstract: A process to invert a structure, for example a vehicle body after an equipment mounting phase, namely of mobility means, on the underside of said structure, process wherein the structure is made to swivel around an instantaneous axis of rotation which is perpendicular to the longitudinal axis of the structure, such axis of rotation being located in the vicinity of a first end of the structure, maneuvering means being positioned at the other end of the structure to control this swiveling.

Abstract: A handling process for a wheel of large mass from a storage position, in particular to enable its mounting onto the hub of a vehicle, wherein said process comprises the following steps: a handling device that comprises at least two flexible non-elastic attachments parallel to one another and linked by at least two flexible and non-elastic fastening means is positioned on said wheel, said attachments and said fastening means enable the tire tread mounted on said wheel to be encircled over substantially 360°, said attachment thus being position at each side flank of said wheel, the ends of said different flexible attachments are brought together so as to imprison said wheel within said handling device, said ends of said different flexible attachments of said handling device are hooked onto a handling and lifting device, such as a winch integral with a bridge crane, said bridge crane ensuring the lifting and displacement of said wheel.

Abstract: An assembly process for a vehicle of substantial height, process in which at least one pit is implemented that is able to accommodate the vehicle, the latter being positioned on at least one removable floor platform able to raise the vehicle with respect to the bottom of the pit, the floor platform being positioned at the required height by means of positioning means.

Abstract: A process to invert a structure, for example a vehicle body after an equipment mounting phase, namely of mobility means, on the underside of said structure, process wherein the structure is made to swivel around an instantaneous axis of rotation which is perpendicular to the longitudinal axis of the structure, such axis of rotation being located in the vicinity of a first end of the structure, maneuvering means being positioned at the other end of the structure to control this swiveling.

Abstract: The present invention relates to a process for preparing 17?-acetoxy-6-methylenepregn-4-ene-3,20-dione (4) as an intermediate, and to processes for preparing medroxyprogesterone acetate (1) (17?-acetoxy-6?-methylpregn-4-ene-3,20-dione) and megestrol acetate (2) (17?-acetoxy-6-methylpregna-4,6-diene-3,20-dione) via this intermediate (4).

Abstract: A process for obtaining aminopolyamide-epichlorohydrin resins with a 1,3-dichloro-2-propanol content which is undetectable by ordinary means of vapor-phase chromatography. The process consists of passing the products resulting from the successive condensation of aminopolyamides and epichlorohydrin through two columns of activated carbon. In this way, aqueous resins are obtained which are free of toxic products, and which are particularly valuable as wet strength additives in the manufacture of papers for medical, cosmetic or food contact uses.

Abstract: 3-Oxyiminopregnane-21-carbolactones of formula I, wherein R is as defined by the specification, their production and use as pharmaceutical agents are described.

Abstract: This invention relates to (R)-(-)-methylphenyloxazolidinone derivatives, a process for their production and their use as pharmaceutical agents.

Abstract: Described are racemic and enantiomerically pure chiral phenyldihydrofuranones, their preparation and their use in drugs (selective inhibition of the cAMP-specific phosphodiesterase IV).

Abstract: Pharmaceutical preparations for the local treatment of inflammations are claimed herein, characterized in that they contain as the active ingredient one or two compounds of general Formula I ##STR1## wherein X is an oxygen atom or a methylene group,R.sub.1 and R.sub.2 represent a hydrogen atom or a hydrocarbon residue of maximally eight carbon atoms, optionally interrupted by an oxygen atom,R.sub.3 is a hydrogen atom or a hydrocarbon residue of maximally eight carbon atoms, optionally substituted by an oxo group, andR.sub.4 is a hydrogen atom or an alkyl group of maximally four carbon atoms.

Abstract: An agent for transdermal administration is described, which is characterized in that it contains gestodene esters with 1 to 20 carbon atoms in the ester radical optionally in combination with one or two estrogen(s).

Abstract: Pharmaceutical preparations for the local treatment of inflammations are claimed herein, characterized in that they contain as the active ingredient one or two compounds of general Formula I ##STR1## wherein X is an oxygen atom or a methylene group,R.sub.1 and R.sub.2 represent a hydrogen atom or a hydrocarbon residue of maximally eight carbon atoms, optionally interrupted by an oxygen atom,R.sub.3 is a hydrogen atom or a hydrocarbon residue of maximally eight carbon atoms, optionally substituted by an oxo group, andR.sub.4 is a hydrogen atom or an alkyl group of maximally four carbon atoms.

Abstract: Synthetically produced cephalostatin analogues of the formula I described in the disclosure, synthetic methods for preparing the cephalostatin analogues, pharmaceutical compositions containing the analogues and methods for using the analogues as active agent in pharmaceutical uses, particularly due to their cytotoxic activity.

Abstract: Glucocorticoids of general formula IR--Val--O--GC (II),are described,in whichO-GC is the radical of a 21-hydroxycorticoid that has an antiinflammatory action,Val represents a valine radical in the 21-position of the corticoid andR means a hydrogen atom or a hydrocarbon radical with up to 32 carbon atoms that is optionally substituted by hydroxy groups, amino groups, oxo groups and/or halogen atoms and/or interrupted by oxygen atoms, SO.sub.2 groups and/or NH groups and their salts.

Abstract: A 14.alpha.,17.alpha.-bridged estratriene of formula I ##STR1## wherein (a) OR.sup.3 is in .alpha.-positionR.sup.1, R.sup.2 and R.sup.3, each independently are (i) hydrogen, (ii) ##STR2## in which R.sup.4 is an organic radical with up to 11 carbon atoms or (iii) --(CH.sub.2).sub.n COOH wherein n=1-4, or (iv) R.sup.1 is a benzyl, C.sub.1 -C.sub.8 alkyl or C.sub.3 -C.sub.5 cycloalkyl, or(b) OR.sup.3 is in .beta.-positionR.sup.1, R.sup.2 and R.sup.3, each independently are (i) hydrogen, (ii) an acyl group with 1 to 12 carbon atoms or (iii) R.sup.1 is C.sub.1 -C.sub.8 alkyl, and in both (a) and (b) A--B is an etheno or ethano bridge.

Abstract: The new 14.alpha.,16.alpha.-ethano- and 14.alpha.,16.alpha.-etheno-estratrienes of general formula I, ##STR1## are described, in which A-B means a C-C single bond or C-C double bond,R.sub.1 means a hydrogen atom, a methyl or acyl group with 1-12 carbon atoms andX means oxygen or ##STR2## in which R.sub.2 represents a hydrogen atom or an acyl group with 1-12 carbon atoms,and a process for their production. The new compounds are very strong estrogens and are suitable for the production of pharmaceutical agents.

Abstract: A process for the production of 3-deoxy-4-ene steroids of the general formula I ##STR1## is described, in which R.sub.1, R.sub.2 and R.sub.3 mean a hydrogen atom or a methyl group,R.sub.4 represents a lower alkyl group, a phenyl group or a free, esterified or etherified hydroxy group,R.sub.5 symbolizes a hydrogen atom, a vinyl group or the grouping --C.tbd.CR.sub.6 with R.sub.6 meaning a hydrogen atom, an alkyl group with a maximum of 4 carbon atoms or a halogen atom,X represents a methylene group, a fluoromethylene group, an ethylidene group or a vinylidene group,Y and U represent a methylene group or an ethylidene group andZ symbolizes a methylene group, an ethylidene group, a vinylidene group, a chloromethylene group or a hydroxymethylene group and in which the bonds represent three single bonds or one double bond and two single bonds or a conjugated double bond.